Status:
COMPLETED
Soluble CD146 and Proteinuria in Chronic Renal Disease
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Chronic Renal Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chronic renal disease (CKD) is defined as a decrease in glomerular filtration rate (GFR) and / or proteinuria or albuminuria (a protein present in urine). Albuminuria is considered a marker of endothe...
Eligibility Criteria
Inclusion
- Adult subject aged 18 years or over
- Subject capable of giving informed consent
- Patient with chronic kidney disease (stage 1 to 5 CKD regardless of etiology)
Exclusion
- Pregnant or lactating woman
- Person deprived of liberty or hospitalized without consent
- Major under legal protection or unable to express his consent
- Refusal of the patient
- Patient with a history of kidney transplantation
- Evolutionary cancer
Key Trial Info
Start Date :
February 28 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 26 2023
Estimated Enrollment :
204 Patients enrolled
Trial Details
Trial ID
NCT03341949
Start Date
February 28 2018
End Date
May 26 2023
Last Update
May 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hôpitaux de Marseille
Marseille, France, 13354